U.S. defense sector stocks are posting modest gains in pre-market trading following Donald Trump’s announcement that the U.S. government will allocate $25 billion (as part of a targeted $175 billion) for the construction of a missile defense system. The system is expected to take three years to build and will ultimately cover the United States — and likely Canada as well — under the NORAD framework.
Analysts note that over a 20-year horizon, the so-called “Iron Dome” will cost the U.S. budget more than $800 billion. The project will involve missile, satellite, and advanced tech systems, potentially benefiting companies such as Raytheon (RTX Corp) and L3Harris, both of which play a major role in missile and hypersonic technologies.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appRTX Corp (RTX.US, H1 interval)
While RTX Corp shares are trading near all-time highs, L3Harris and Lockheed Martin stocks are still attempting to regain strength after recent sell-offs.
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.